Cipher Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 7.56% vs 4.24% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 115.79% vs -19.15% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.50",
          "val2": "17.20",
          "chgp": "7.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.40",
          "val2": "6.00",
          "chgp": "56.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.70",
          "chgp": "-28.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.20",
          "val2": "3.80",
          "chgp": "115.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "373.00%",
          "val2": "195.20%",
          "chgp": "17.78%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 59.79% vs 6.32% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -42.55% vs -20.75% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.70",
          "val2": "28.60",
          "chgp": "59.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.50",
          "val2": "15.20",
          "chgp": "-17.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.80",
          "val2": "27.50",
          "chgp": "-42.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "153.90%",
          "val2": "474.10%",
          "chgp": "-32.02%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

18.50

17.20

7.56%

Operating Profit (PBDIT) excl Other Income

9.40

6.00

56.67%

Interest

0.50

0.70

-28.57%

Exceptional Items

0.00

0.00

Consolidate Net Profit

8.20

3.80

115.79%

Operating Profit Margin (Excl OI)

373.00%

195.20%

17.78%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.56% vs 4.24% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 115.79% vs -19.15% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

45.70

28.60

59.79%

Operating Profit (PBDIT) excl Other Income

12.50

15.20

-17.76%

Interest

0.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

15.80

27.50

-42.55%

Operating Profit Margin (Excl OI)

153.90%

474.10%

-32.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 59.79% vs 6.32% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -42.55% vs -20.75% in Dec 2023

All Annual Results